155 related articles for article (PubMed ID: 31841869)
1. Development and evaluation of a harmonized whole body physiologically based pharmacokinetic (PBPK) model for flutamide in rats and its extrapolation to humans.
Sharma RP; Kumar V; Schuhmacher M; Kolodkin A; Westerhoff HV
Environ Res; 2020 Mar; 182():108948. PubMed ID: 31841869
[TBL] [Abstract][Full Text] [Related]
2. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
[TBL] [Abstract][Full Text] [Related]
3. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
[TBL] [Abstract][Full Text] [Related]
4. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
5. Review on crosstalk and common mechanisms of endocrine disruptors: Scaffolding to improve PBPK/PD model of EDC mixture.
Sharma RP; Schuhmacher M; Kumar V
Environ Int; 2017 Feb; 99():1-14. PubMed ID: 27697394
[TBL] [Abstract][Full Text] [Related]
6. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
7. Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors.
Frederick CB; Lomax LG; Black KA; Finch L; Scribner HE; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB
Toxicol Appl Pharmacol; 2002 Aug; 183(1):23-40. PubMed ID: 12217639
[TBL] [Abstract][Full Text] [Related]
8. Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
Karrer C; Roiss T; von Goetz N; Gramec Skledar D; Peterlin Mašič L; Hungerbühler K
Environ Health Perspect; 2018 Jul; 126(7):077002. PubMed ID: 29995627
[TBL] [Abstract][Full Text] [Related]
9. A hybrid computational fluid dynamics and physiologically based pharmacokinetic model for comparison of predicted tissue concentrations of acrylic acid and other vapors in the rat and human nasal cavities following inhalation exposure.
Frederick CB; Gentry PR; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
Inhal Toxicol; 2001 May; 13(5):359-76. PubMed ID: 11295868
[TBL] [Abstract][Full Text] [Related]
10. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
Chiu WA; White P
Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.
Song G; Moreau M; Efremenko A; Lake BG; Wu H; Bruckner JV; White CA; Osimitz TG; Creek MR; Hinderliter PM; Clewell HJ; Yoon M
Toxicol Sci; 2019 Jun; 169(2):365-379. PubMed ID: 30768128
[TBL] [Abstract][Full Text] [Related]
12. Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling.
Williams RJ; Vinegar A; McDougal JN; Jarabek AM; Fisher JW
Fundam Appl Toxicol; 1996 Mar; 30(1):55-66. PubMed ID: 8812223
[TBL] [Abstract][Full Text] [Related]
13. The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data.
Sharma RP; Schuhmacher M; Kumar V
Sci Total Environ; 2018 May; 624():55-68. PubMed ID: 29247905
[TBL] [Abstract][Full Text] [Related]
14. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.
Tan YM; Liao KH; Clewell HJ
J Expo Sci Environ Epidemiol; 2007 Nov; 17(7):591-603. PubMed ID: 17108893
[TBL] [Abstract][Full Text] [Related]
15. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
Chou WC; Lin Z
Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
[TBL] [Abstract][Full Text] [Related]
16. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.
Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P
Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
[TBL] [Abstract][Full Text] [Related]
18. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
19. Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.
Wong YC; Centanni M; de Lange ECM
J Clin Pharmacol; 2019 May; 59(5):731-747. PubMed ID: 30676661
[TBL] [Abstract][Full Text] [Related]
20. Toxicokinetic modeling and its applications in chemical risk assessment.
Andersen ME
Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
